NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | -97.4% | 80 | -97.2% | 0.01% | -94.8% |
| Q3 2021 | $230,000 | -29.4% | 2,827 | -21.0% | 0.23% | -8.7% |
| Q2 2021 | $326,000 | -51.6% | 3,577 | -54.7% | 0.25% | -53.9% |
| Q1 2021 | $674,000 | +28.9% | 7,896 | +425.0% | 0.55% | +15.3% |
| Q4 2020 | $523,000 | +8.5% | 1,504 | -72.9% | 0.48% | -12.8% |
| Q3 2020 | $482,000 | -0.4% | 5,542 | 0.0% | 0.55% | -14.7% |
| Q2 2020 | $484,000 | -8.7% | 5,542 | -13.9% | 0.64% | -31.8% |
| Q1 2020 | $530,000 | -40.0% | 6,438 | -31.0% | 0.94% | -26.0% |
| Q4 2019 | $884,000 | +18.2% | 9,327 | +8.4% | 1.27% | +122.1% |
| Q3 2019 | $748,000 | -16.5% | 8,604 | -12.2% | 0.57% | +252.5% |
| Q2 2019 | $896,000 | -1.6% | 9,805 | +4.0% | 0.16% | -6.4% |
| Q1 2019 | $911,000 | +85.2% | 9,424 | +64.4% | 0.17% | +66.3% |
| Q4 2018 | $492,000 | – | 5,731 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |